Photo provided = AI-generated image S-Biomedics has decided to issue KRW 22.2 billion in convertible bonds to secure funding for research and development of its cell therapy pipeline. S-Biomedics announced in a filing on the 14th that it would issue its seventh series of unregist
2026-04-14
Photo provided = AI-generated image U.S. protein sequencing company Alamar Biosciences is pursuing an initial public offering (IPO) of up to $159 million (approximately 229 billion won). On the 14th, local time, biotech publication Fierce Biotech reported the news, citing documen
2026-04-14
Photo provided = AI-generated image Eli Lilly is strengthening its ADC pipeline by acquiring antibody-drug conjugate (ADC) biotech CrossBridge Bio in a deal valued at $300 million (approximately 432 billion won). According to biopharmaceutical news outlet Fierce Biotech on the 14
2026-04-14
Photo provided = AI-generated image Novo Nordisk, a company specializing in obesity and diabetes treatments, is partnering with OpenAI, the developer of ChatGPT, to use artificial intelligence (AI) in drug development. Novo Nordisk officially announced the partnership with OpenAI
2026-04-14
Photo provided = AI-generated image Hyundai Pharm, which is developing South Korea’s first four-drug combination for hypertension and hyperlipidemia, has voluntarily discontinued its approved Phase 3 trial and will pursue marketing approval through a shorter pathway. Hyundai Phar
2026-04-14
Photo provided = AI-generated image S-Biomedics is moving to raise funds for research and development (R&D) of its cell therapy pipeline. S-Biomedics announced that its board of directors met on the 14th and decided on a third-party allotment of paid-in capital increase worth app
2026-04-14
Photo provided = AI-generated image The Indian government has declared its intention to move beyond its status as the “world’s pharmacy” and become a “global biotech hub,” backed by an investment of more than 1.7 trillion won. According to Indian media outlet Express Pharma on th
2026-04-14
Photo provided = AI-generated image Vital Medtech unveiled a vertically integrated solution spanning key components to finished systems for medical imaging equipment based on semiconductor technology. On the 14th, Vital Medtech, the medical and health care division of Vital Group
2026-04-14
Penetrium Bio Behind Penetrium Bioscience’s market capitalization of more than 600 billion won, built on a single anticancer drug candidate derived from an anthelmintic ingredient, lies a financial structure governed by calculations entirely different from the stock’s market ferv
2026-04-14
Inventage Lab Inventage Lab, which posted a consolidated operating loss of 28.3 billion won, has mounted a direct challenge to Halozyme, a leader in the global subcutaneous (SC) formulation market. Hana Securities said in a report on the 14th that Inventage Lab had added the anti
2026-04-14
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
